Mechanisms of angiogenesis and remodelling of the microvasculature

Cardiovascular Research

Volumn 78, Issue 2, 2008, Pages 201-202

  Silvestre, Jean Sebastien ^a   Lévy, Bernard I ^a   Tedgui, Alain ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; CHEMOKINE; EPOXYICOSATRIENOIC ACID; FIBROBLAST GROWTH FACTOR; GELATINASE A; GELATINASE B; GROWTH FACTOR; INTEGRIN; SPHINGOSINE 1 PHOSPHATE; SYNDECAN 4; VASCULOTROPIN; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; CAPILLARY DENSITY; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CLINICAL RESEARCH; DIABETES MELLITUS; EDITORIAL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; ISCHEMIA; MICROVASCULATURE; NERVE DEGENERATION; OSTEOPOROSIS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RESPIRATORY TRACT DISEASE; RISK FACTOR; SIGNAL TRANSDUCTION; SMOKING; STEM CELL; TUMOR GROWTH;

ANGIOGENESIS MODULATING AGENTS; ANGIOGENIC PROTEINS; ANIMALS; ENDOTHELIAL CELLS; HUMANS; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION;

EID: 42349110216     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn070     Document Type: Editorial

References (20)

1. Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 2004;3:391-400.
2. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653-660.
3. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-1221.
4. Van Hinsbergh VWM, Koolwijk P. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res 2008;78:203-212.
5. Serini G, Napione L, Arese M, Bussolino F. Besides adhesion: new perspectives of integrin functions in angiogenesis. Cardiovasc Res 2008;78:213-222.
6. Tongers J, Knapp JM, Korf M, Kempf T, Limbourg A, Limbourg FP et al. Haeme oxygenase promotes progenitor cell mobilization, neovascularization, and functional recovery after critical hind-limb ischaemia in mice. Cardiovasc Res 2008;78:294-300.
7. Oyama O, Sugimoto N, Qi X, Takuwa N, Mizugishi K, Koizumi J et al. The lysophospholipid mediator sphingosine-1-phosphate promotes angiogenesis in vivo in ischemic hindlimbs of mice. Cardiovasc Res 2008;78:301-307.
8. Yan G, Chen S, You B, Sun J. Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids. Cardiovasc Res 2008;78:308-314.
9. Benest AV, Harper SJ, Yla Herttuala S, Alitalo K, Bates DO. VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis. Cardiovasc Res 2008;78:315-323.
10. Murakami M, Elfenbein A, Simons M. Non-canonical fibroblast growth factor signalling in angiogenesis. Cardiovasc Res 2008;78:223-231.
11. Le Noble F, Klein C, Tintu A, Pries A, Buschmann I. Neural guidance molecules, tip cells and mechanical factors in vascular development. Cardiovasc Res 2008;78:232-241.
12. Krishnan L, Underwood CJ, Maas S, Ellis BJ, Kode TC, Hoying JB et al. Effect of mechanical boundary conditions on orientation of angiogenic microvessels. Cardiovasc Res 2008;78:324-332.
13. Silvestre JS, Mallat Z, Tedgui A, Levy BI. Post-ischaemic neovascularization and inflammation. Cardiovasc Res 2008;78:242- 249.
14. Balestrieri ML, Balestrieri A, Mancini FP, Napoli C. Understanding the immunoangiostatic CXC chemokine network. Cardiovasc Res 2008;78:250-256.
15. Ryu J, Lee CW, Hong KH, Shin JA, Lim SH, Park CS et al. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Cardiovasc Res 2008;78:333-340.
16. Bakker ENTP, Matlung HL, Bonta P, de Vries CJ, van Rooijen N, VanBavel E. Blood flow-dependent arterial remodelling is facilitated by inflammation but directed by vascular tone. Cardiovasc Res 2008;78:341-348.
17. Kinnaird T, Stabile E, Zbinden S, Burnett MS, Epstein SE. Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions. Cardiovasc Res 2008;78:257-264.
18. Spinetti G, Kraenkel N, Emanueli C, Madeddu P. Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. Cardiovasc Res 2008;78:265-273.
19. Feihl F, Liaudet L, Levy BI, Waeber B. Hypertension and microvascular remodelling. Cardiovasc Res 2008;78:274-285.
20. Lijnen HR. Angiogenesis and obesity. Cardiovasc Res 2008;78:286-293.